Changes in first-line injectable disease-modifying therapy for multiple sclerosis: predictors of non-adherence, switching, discontinuation, and interruption of drugs
Crossref DOI link: https://doi.org/10.1007/s10072-016-2806-4
Published Online: 2017-01-11
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Degli Esposti, Luca
Piccinni, Carlo
Sangiorgi, Diego
Perrone, Valentina
Aledda, Lucia
Marrosu, Maria Giovanna
Lombardo, Fabio
License valid from 2017-01-11